Home > Result Summaries: Compounds > umeclidinium bromide > Result Summary for 113589

Result Summary for 113589

Result Summary

Protocol ID:	113589
Clinical Study ID:	AC4113589
Official Title:	A randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of GSK573719 delivered once-daily over 28 days in subjects with COPD
Phase:	phase 2
Study Indications or Diseases:	Pulmonary Disease, Chronic Obstructive
Generic Name:	umeclidinium bromide
Trade/Product Name:	umeclidinium bromide
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Decramer M, Maltais F, Feldman G, Brooks J, Harris S, Mehta R, Crater G. Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients. Respir Physiol Neurobiol. 2013;185(2):393-399.